Merck Rupintrivir

Rupintrivir

≥98% (HPLC)

Ethyl (E,4S)-4-[[(2R,5S)-2-[(4-fluorophenyl)methyl]-6-methyl-5-[(5-methyl-1,2-oxazole-3-carbonyl)amino]-4-oxoheptanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate, AG7088, Ruprintrivir, AG-7088

Quality Level

100

assay

≥98% (HPLC)

form

powder

광학 활성

[α]/D +30 to +40°, c = 0.5 in chloroform-d

manufacturer/tradename

Pfizer®

색상

white to beige

solubility

DMSO: 25 mg/mL, clear

주관자

Pfizer

저장 온도

room temp

InChI

1S/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1

InChI key

CAYJBRBGZBCZKO-BHGBQCOSSA-N

Rupintrivir is an irreversible peptidomimetic inhibitor designed to target human rhinovirus (HRV). It was previously named as AG7088. It has been suggested that rupintrivir may be involved in vitro antiviral activity.